PIMAVANSERIN TARTRATE | A214925 | MSN LABORATORIES PRIVATE LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
ACADIA Pharmaceuticals Inc. v. MSN Laboratories Private Limited et al 2 patentsANDA 214925pimavanserin tartrate | D. Del. | 2020-07-30 | Terminated 2024-01-11 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Zydus Pharmaceuticals (USA) Inc. FDA-2024-P-2514 · 4 docket documents Zydus Pharmaceuticals (USA) Inc. filed this petition on May 22, 2024, requesting that the FDA determine whether NUPLAZID (pimavanserin) tablets, 17 mg (NDA N207318), held by Acadia Pharmaceuticals Inc., was withdrawn from commercial sale for reasons of safety or effectiveness or for commercial reaso | 505(q) | 2024-05-23 | Granted | Zydus Pharmaceuticals (USA) Inc. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.